A detailed history of Mendota Financial Group, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Mendota Financial Group, LLC holds 33 shares of NVO stock, worth $2,903. This represents 0.0% of its overall portfolio holdings.

Number of Shares
33
Previous 58 43.1%
Holding current value
$2,903
Previous $6.91 Million 58.9%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 13, 2025

SELL
$85.0 - $120.04 $2,125 - $3,001
-25 Reduced 43.1%
33 $2.84 Million
Q3 2024

Oct 09, 2024

BUY
$119.07 - $145.42 $2,024 - $2,472
17 Added 41.46%
58 $6.91 Million
Q2 2024

Jul 11, 2024

BUY
$122.71 - $146.91 $5,031 - $6,023
41 New
41 $5.85 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $199B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Mendota Financial Group, LLC Portfolio

Follow Mendota Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mendota Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mendota Financial Group, LLC with notifications on news.